Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Common Equity (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Common Equity for 3 consecutive years, with $217.9 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 45.31% to $217.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217.9 million through Dec 2025, up 45.31% year-over-year, with the annual reading at $217.9 million for FY2025, 45.31% up from the prior year.
  • Common Equity hit $217.9 million in Q4 2025 for Guardian Pharmacy Services, up from $195.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $217.9 million in Q4 2025 to a low of $56.6 million in Q1 2024.
  • Historically, Common Equity has averaged $127.4 million across 3 years, with a median of $141.9 million in 2024.
  • Biggest YoY gain for Common Equity was 214.04% in 2025; the steepest drop was 45.31% in 2025.
  • Year by year, Common Equity stood at $59.9 million in 2023, then skyrocketed by 150.55% to $150.0 million in 2024, then surged by 45.31% to $217.9 million in 2025.
  • Business Quant data shows Common Equity for GRDN at $217.9 million in Q4 2025, $195.5 million in Q3 2025, and $179.7 million in Q2 2025.